Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-26-082018

Options or other derivatives

  • CFO acquired 92,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kolean Chad J CFO 2026-07-07 Grant or award · Stock option (right to buy) +92,000 92,000 D
Loading xslF345X06/tm2620095-9_4seq1.xml…